A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
about
Evaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancerA double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer.Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.Gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer: a prospective observational study.Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer.Gemcitabine in combination with 5-fluorouracil with or without folinic acid in the treatment of pancreatic cancer.A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer.A novel biweekly pancreatic cancer treatment schedule with gemcitabine, 5-fluorouracil and folinic acid.A phase II irinotecan-cisplatin combination in advanced pancreatic cancer.Preclinical Rationale for the Phase III Trials in Metastatic Pancreatic Cancer: Is Wishful Thinking Clouding Successful Drug Development for Pancreatic Cancer?A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.
P2860
Q28729144-CF359E0E-15E1-450B-925E-AA6807130E11Q30438645-1D6715B1-5E5E-4469-92E8-977C3F2B24C4Q33338535-211B5B12-20C3-420F-A275-131F668C163EQ33347231-F7193CA5-EC03-441A-89C7-A44EF17FC062Q33366682-DA8964AB-2B6C-4E39-BA86-20B8D2655273Q34810745-746279BA-C170-47AE-BD7F-E3F75E9DF7D7Q36644598-23A3A3D3-C133-4456-ADA0-12EA0A6A9C7FQ36670901-8A20C586-E7C6-41FD-B5A4-D1A26C9B6CFEQ36671589-B80FD077-6B2E-40C4-B4CB-113730671511Q39022032-423A1951-218C-4B8F-A4B1-C384D0734B20Q43869761-740F88DC-A88B-461D-88F3-5609CDAC3273
P2860
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
A combination of gemcitabine a ...... gestive Tract Cancer (GISCAD).
@ast
A combination of gemcitabine a ...... gestive Tract Cancer (GISCAD).
@en
A combination of gemcitabine a ...... gestive Tract Cancer (GISCAD).
@nl
type
label
A combination of gemcitabine a ...... gestive Tract Cancer (GISCAD).
@ast
A combination of gemcitabine a ...... gestive Tract Cancer (GISCAD).
@en
A combination of gemcitabine a ...... gestive Tract Cancer (GISCAD).
@nl
prefLabel
A combination of gemcitabine a ...... gestive Tract Cancer (GISCAD).
@ast
A combination of gemcitabine a ...... gestive Tract Cancer (GISCAD).
@en
A combination of gemcitabine a ...... gestive Tract Cancer (GISCAD).
@nl
P2093
P2860
P356
P1476
A combination of gemcitabine a ...... gestive Tract Cancer (GISCAD).
@en
P2093
G Catalano
G Luporini
L Frontini
L Giuliodori
P Giordani
R Cellerino
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690568
P407
P577
1999-07-01T00:00:00Z
P5875
P6179
1007261037